Clinical Trial

Cerebral Embolic Protection Device During TAVR

Name: Cerebral Embolic Protection Device During TAVR — clinical trial record (NCT07627984)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

To evaluate the safety and effectiveness of the Cerebral Protection System (model CEP016F, Shanghai Shenqi Medical Technology Co., Ltd.) for capturing and removing thrombotic and tissue debris during transcatheter aortic valve replacement (TAVR).

Trial Details

NCT Number	NCT07627984
Lead Sponsor	Shanghai Shenqi Medical Technology Co., Ltd
Conditions	Cerebral Embolicprotection Device, TAVR
Enrollment	260 participants
Start Date	2023-09-20
Primary Completion	2025-04-16 (estimated)
Study Completion	2025-04-16 (estimated)
Updated on ClinicalTrials.gov	2026-06-04